Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-02-01
|
| Series: | JAAD Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512622005410 |
| _version_ | 1797904284401008640 |
|---|---|
| author | Neda Shahriari, MD Daniel R. Mazori, MD Joseph F. Merola, MD, MMSc |
| author_facet | Neda Shahriari, MD Daniel R. Mazori, MD Joseph F. Merola, MD, MMSc |
| author_sort | Neda Shahriari, MD |
| collection | DOAJ |
| first_indexed | 2024-04-10T09:47:38Z |
| format | Article |
| id | doaj.art-6c76908b768d4575a6998a4950e6dd35 |
| institution | Directory Open Access Journal |
| issn | 2352-5126 |
| language | English |
| last_indexed | 2024-04-10T09:47:38Z |
| publishDate | 2023-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JAAD Case Reports |
| spelling | doaj.art-6c76908b768d4575a6998a4950e6dd352023-02-17T04:54:55ZengElsevierJAAD Case Reports2352-51262023-02-01324143Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% creamNeda Shahriari, MD0Daniel R. Mazori, MD1Joseph F. Merola, MD, MMSc2Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts; Correspondence to: Neda Shahriari, MD, Department of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, 221 Longwood Avenue Boston, MA 02115.Ronald O. Perelman Department of Dermatology, New York University Grossman School of Medicine, New York, New YorkDepartment of Dermatology, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts; Division of Rheumatology, Inflammation, and Immunity, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusettshttp://www.sciencedirect.com/science/article/pii/S2352512622005410IVIgJAK inhibitionnecrobiotic xanthogranulomatofacitinib |
| spellingShingle | Neda Shahriari, MD Daniel R. Mazori, MD Joseph F. Merola, MD, MMSc Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream JAAD Case Reports IVIg JAK inhibition necrobiotic xanthogranuloma tofacitinib |
| title | Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream |
| title_full | Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream |
| title_fullStr | Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream |
| title_full_unstemmed | Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream |
| title_short | Intravenous immunoglobulin–refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2% cream |
| title_sort | intravenous immunoglobulin refractory necrobiotic xanthogranuloma successfully treated with tofacitinib 2 cream |
| topic | IVIg JAK inhibition necrobiotic xanthogranuloma tofacitinib |
| url | http://www.sciencedirect.com/science/article/pii/S2352512622005410 |
| work_keys_str_mv | AT nedashahriarimd intravenousimmunoglobulinrefractorynecrobioticxanthogranulomasuccessfullytreatedwithtofacitinib2cream AT danielrmazorimd intravenousimmunoglobulinrefractorynecrobioticxanthogranulomasuccessfullytreatedwithtofacitinib2cream AT josephfmerolamdmmsc intravenousimmunoglobulinrefractorynecrobioticxanthogranulomasuccessfullytreatedwithtofacitinib2cream |